Main Content


Study title

Avastin plus Chemotherapy versus Avastin plus Chemotherapy versus Avastin plus Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients with Recurrent Plantinum-Resistant or –Sensitive Epithelial Ovarian, Fallopian tube, or Primary Peritoneal Cancer

  • Principal Investigator: Dr. Kelly Wilkinson


The purpose of this study is to screen chemotherapy drugs that are currently being used for the care of recurrent ovarian cancer and to determine the most effective treatment.

Who can participate

Those eligible to participate in this study include:

  • Women ages 18 and older who have ovarian cancer

For more information

  • Sandra Powe
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson, MS 39216
    (601) 984-1965
  • IRB Number: 2018-0147